Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

Refractory chronic GVHD (cGVHD) is an important complication after allogeneic hematopoietic SCT and is prognostic of poor outcome. MSCs are involved in tissue repair and modulating immune responses in vitro and in vivo. From April 2005 to October 2008, 19 patients with refractory cGVHD were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, J Y, Du, X, Geng, S X, Peng, Y W, Wang, Z, Lu, Z S, Wu, S J, Luo, C W, Guo, R, Ling, W, Deng, C X, Liao, P J, Xiang, A P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035976/
https://www.ncbi.nlm.nih.gov/pubmed/20818445
http://dx.doi.org/10.1038/bmt.2010.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035976/
https://www.ncbi.nlm.nih.gov/pubmed/20818445
http://dx.doi.org/10.1038/bmt.2010.195

Ejemplares similares